GitaV.MasseyMD

Pediatric Hematology & Oncology • Richmond, VA

Children's Hospital of Richmond (CHoR) Division of Pediatric Hematology-Oncology

Join to view full profile

Dr. Massey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Massey's full profile

Already have an account?

Office
1000 E. Broad ST - 1st floor
Pediatric Hematology-Oncology
Richmond, VA 23298
Phone+1 804-828-9605

Fax+1 804-628-0070

Education & Training

Virginia Commonwealth University Health SystemFellowship, Hematology and Medical Oncology, 1985 - 1988
Virginia Commonwealth University Health SystemResidency, Pediatrics, 1981 - 1985
Virginia Commonwealth University School of MedicineClass of 1981

Certifications & Licensure

VA State Medical License 1986 - 2026
American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Correlation Between Vitamin D Status and Bone Mineral Density in Patients With Hemophilia Start of enrollment: 2010 Mar 01
Completed
Not Applicable
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients Start of enrollment: 2012 Jun 01
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas Start of enrollment: 2013 Jun 17
Active, not recruiting
Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients. Start of enrollment: 2013 Aug 20
Completed
Phase 2
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Start of enrollment: 2014 Jul 11
Active, not recruiting
Phase 2, Phase 3
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
Join now to see all

Publications & Presentations

PubMed

1 citations
Congenital dyserythropoietic anemia type IV with KLF1 E325K mutation: A new case with dysmorphic male genitalia.
Gita V Massey, Alden Chesney, Manisha Gadgeel, Yaddanapudi Ravindranath
Pediatric Blood & Cancer. 2024-06-01
Medich Giant Platelet Syndrome: An Evolving Qualitative and Quantitative Platelet Disorder.
Gita Massey, Laura Tyrrell, Yaser Diab, William T Gunning 3rd
Hematology Reports. 2022-12-01
14 citations
Real-world cost estimates of initiating emicizumab in US patients with haemophilia A.
Benjamin J. Samelson-Jones, Christine Guelcher, Jan G. Kuhn, Regina Butler, Gita Massey
Haemophilia. 2021-05-29